DE2302668A1 - 5-aroyl-2-(tetrazol-2-ylmethyl)pyrrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate - Google Patents

5-aroyl-2-(tetrazol-2-ylmethyl)pyrrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate

Info

Publication number
DE2302668A1
DE2302668A1 DE2302668A DE2302668A DE2302668A1 DE 2302668 A1 DE2302668 A1 DE 2302668A1 DE 2302668 A DE2302668 A DE 2302668A DE 2302668 A DE2302668 A DE 2302668A DE 2302668 A1 DE2302668 A1 DE 2302668A1
Authority
DE
Germany
Prior art keywords
tetrazol
hydrogen atom
aroyl
ylmethyl
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE2302668A
Other languages
German (de)
English (en)
Inventor
John Robert Carson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
McNeilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McNeilab Inc filed Critical McNeilab Inc
Publication of DE2302668A1 publication Critical patent/DE2302668A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
DE2302668A 1972-01-21 1973-01-19 5-aroyl-2-(tetrazol-2-ylmethyl)pyrrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate Ceased DE2302668A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21986372A 1972-01-21 1972-01-21

Publications (1)

Publication Number Publication Date
DE2302668A1 true DE2302668A1 (de) 1973-07-26

Family

ID=22821076

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2302668A Ceased DE2302668A1 (de) 1972-01-21 1973-01-19 5-aroyl-2-(tetrazol-2-ylmethyl)pyrrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate

Country Status (9)

Country Link
JP (1) JPS5632991B2 (no)
AT (1) AT321298B (no)
AU (1) AU464772B2 (no)
BE (1) BE794162A (no)
CA (1) CA1018980A (no)
CH (1) CH575411A5 (no)
DE (1) DE2302668A1 (no)
FR (1) FR2183660B1 (no)
GB (1) GB1390346A (no)

Also Published As

Publication number Publication date
FR2183660B1 (no) 1975-10-10
JPS5632991B2 (no) 1981-07-31
FR2183660A1 (no) 1973-12-21
AU464772B2 (en) 1975-09-04
GB1390346A (en) 1975-04-09
CH575411A5 (no) 1976-05-14
BE794162A (fr) 1973-07-17
AT321298B (de) 1975-03-25
JPS4880562A (no) 1973-10-29
CA1018980A (en) 1977-10-11
AU5074273A (en) 1974-07-04

Similar Documents

Publication Publication Date Title
DE2155558C2 (de) Trifluormethyl-diphenyl-imidazole und deren Verwendung
DE1470082C3 (de) Verfahren zur Herstellung von in der 2-Stellung substituierten Benzimidazolen
DE1445186C3 (de) 3,3'-Di-2-imidazolin-2-yl-carbanilid
DE2739912A1 (de) Uracilderivate und herstellungsverfahren
DE2921660A1 (de) 5-nitroimidazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende antiprotozoen-mittel
DE1929950A1 (de) Neue trisubstituierte 2-Arylaminoimidazoline und Verfahren zu deren Herstellung
DE3618724C2 (de) N-[3-(Nitro)-chinol-4-yl]-carboxamidinamide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2302668A1 (de) 5-aroyl-2-(tetrazol-2-ylmethyl)pyrrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
DE2804518A1 (de) Oxadiazolopyrimidin-derivate
DE1927759A1 (de) Neue basische Derivate des Benzoxazolin-2-ons und Verfahren zur Herstellung derselben
DE1901497A1 (de) Neue heterocyclische Verbindungen und Verfahren zu ihrer Herstellung
DE1934392C3 (de) Neue 2-Pyridylthioamide und Verfahren zu ihrer Herstellung
DE69426372T2 (de) Neue 1-Phenylmethyl-benzimidazol-piperazinderivate
DE1470070B1 (de) Verfahren zur Herstellung von Benzimidazolderivaten
DE2166270C3 (de) Nicotinoylaminoäthansulfonyl-2amino-thiazol
DE2550959A1 (de) Neue imidazolverbindungen, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE2046577A1 (de) Neue Pyrimidopyndazinderivate und Verfahren zu ihrer Herstellung
DE2131330A1 (de) Imidazo-[1,2-a]-benzimidazolderivate und Verfahren zur Herstellung derselben
DE1595894A1 (de) Neue 1,5-Diazabicyclo[3,3,0]octan-2,6-dione
DE1947226C3 (de) 1 l-Chlor-8,12b-dihydro-23-dimethyll2b-phenyl-4H [13] -oxazino [3,2-d] [1,4] benzodiazepin-4,7(6H)dion und Verfahren zur Herstellung dieser Verbindung
DE1595875C (de) Phenothiazine und Verfahren zu deren Herstellung
AT228199B (de) Verfahren zur Herstellung eines neuen Imidazolinderivates und seiner Salze
DE1645901C3 (de) gamma-(4-Alkylp!peridino)-p-fluorbutyrophenone und Verfahren zu ihrer Herstellung
DE2002107A1 (de) Neue organische Verbindungen und Verfahren zu deren Herstellung
DE2029510B2 (de) Dibenzofuranderivate und deren pharmazeutisch verträgliche Säureadditionssalze sowie Verfahren zu deren Herstellung und Arzneimittel mit einem Gehalt dieser Verbindungen

Legal Events

Date Code Title Description
OD Request for examination
8131 Rejection